Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ODIXaHIP-OD: Rivaroxaban for VTE Prevention in Hip Replacement
NCT00396786Phase 2Completed
- Sponsor
- Bayer
- Start
- Nov 2004
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of rivaroxaban in venous thromboembolism (VTE), sponsored by Bayer. Started Nov 2004; status: completed.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00396786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396786.